US20170319492A1 - Tamper resistant dosage forms - Google Patents

Tamper resistant dosage forms Download PDF

Info

Publication number
US20170319492A1
US20170319492A1 US15/657,717 US201715657717A US2017319492A1 US 20170319492 A1 US20170319492 A1 US 20170319492A1 US 201715657717 A US201715657717 A US 201715657717A US 2017319492 A1 US2017319492 A1 US 2017319492A1
Authority
US
United States
Prior art keywords
tablet
curing
example
tablets
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/657,717
Inventor
William H. McKenna
Richard O. Mannion
Edward P. O'Donnell
Haiyong H. Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Pharma LP
Purdue Pharmaceuticals LP
Original Assignee
Purdue Pharma LP
Purdue Pharmaceuticals LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US84024406P priority Critical
Priority to US11/844,872 priority patent/US8894987B2/en
Priority to US13/803,132 priority patent/US20140030327A1/en
Priority to US14/515,924 priority patent/US9084816B2/en
Priority to US14/729,593 priority patent/US9486412B2/en
Priority to US15/263,932 priority patent/US9775812B2/en
Application filed by Purdue Pharma LP, Purdue Pharmaceuticals LP filed Critical Purdue Pharma LP
Priority to US15/657,717 priority patent/US20170319492A1/en
Assigned to PURDUE PHARMA L.P. reassignment PURDUE PHARMA L.P. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MANNION, RICHARD O., MCKENNA, WILLIAM H., O'DONNELL, EDWARD P., HUANG, HAIYONG H.
Assigned to PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P. reassignment PURDUE PHARMA L.P. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PURDUE PHARMA L.P.
Publication of US20170319492A1 publication Critical patent/US20170319492A1/en
Application status is Abandoned legal-status Critical

Links